Literature DB >> 30260594

Nicotinate-curcumin ameliorates cognitive impairment in diabetic rats by rescuing autophagic flux in CA1 hippocampus.

Hong-Feng Gu1, Na Li1, Ya-Ling Tang1, Can-Qun Yan2, Zhe Shi3, Si-Ni Yi2, Hao-Ling Zhou2, Duan-Fang Liao3, Xin-Ping OuYang1.   

Abstract

INTRODUCTION: Our previous study has confirmed that a novel curcumin derivate nicotinate-curcumin (NC) can facilitate autophagic flux in THP-1 cells induced by oxidized low-density lipoprotein. AIMS: Given that autophagy plays critical roles in neurodegenerative diseases, the present study was carried out to investigate whether NC can improve cognitive function of rats with diabetes mellitus (DM) via restoring autophagic flux in CA1 hippocampus.
RESULTS: Our results showed that NC treatment improved cognitive deficit and attenuated neuronal loss as well as cellular ultrastructure impairment in the CA1 region of DM rats induced by streptozotocin. Moreover, NC lowered the expressions of the apoptosis-related proteins Bcl-2, Bax, Cyt-c, and cleaved Caspase-3. Notably, NC treatment reversed autophagic flux impairment as evidenced by the deceases in LC3-II and p62 protein levels, and autophagosome accumulation in the hippocampal CA1 region of DM rats. However, these protective effects of NC were abolished by cotreatment with 3-methyladenine (an autophagy inhibitor) and chloroquine (an autophagic flux inhibitor), respectively. Furthermore, NC treatment decreased the expressions of phosphorylated mammalian target of rapamycin (mTOR) and p70 ribosomal protein S6 kinase (p70S6k) proteins in the CA1 region of DM rats.
CONCLUSIONS: These results indicate that NC ameliorates DM-induced cognitive function impairment via restoring autophagic flux might by inhibiting mTOR/p70S6k activation in the CA1 region, and NC may be a promising agent for diabetic cognitive dysfunction prevention and treatment.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  autophagy; cognitive function; diabetes mellitus; hippocampus; mammalian target of rapamycin complex; nicotinate-curcumin

Mesh:

Substances:

Year:  2018        PMID: 30260594      PMCID: PMC6488886          DOI: 10.1111/cns.13059

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  37 in total

Review 1.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 2.  Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration.

Authors:  Rita Maria Concetta Di Martino; Alessandra Bisi; Angela Rampa; Silvia Gobbi; Federica Belluti
Journal:  Expert Opin Ther Pat       Date:  2017-06-19       Impact factor: 6.674

3.  Activation of Autophagic Flux against Xenoestrogen Bisphenol-A-induced Hippocampal Neurodegeneration via AMP kinase (AMPK)/Mammalian Target of Rapamycin (mTOR) Pathways.

Authors:  Swati Agarwal; Shashi Kant Tiwari; Brashket Seth; Anuradha Yadav; Anshuman Singh; Anubha Mudawal; Lalit Kumar Singh Chauhan; Shailendra Kumar Gupta; Vinay Choubey; Anurag Tripathi; Amit Kumar; Ratan Singh Ray; Shubha Shukla; Devendra Parmar; Rajnish Kumar Chaturvedi
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

4.  ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease.

Authors:  Bo-Jeng Wang; Guor Mour Her; Ming-Kuan Hu; Yun-Wen Chen; Ying-Tsen Tung; Pei-Yi Wu; Wen-Ming Hsu; Hsinyu Lee; Lee-Way Jin; Sheng-Ping L Hwang; Rita P-Y Chen; Chang-Jen Huang; Yung-Feng Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-28       Impact factor: 11.205

Review 5.  Curcumin derivatives inhibit or modulate beta-amyloid precursor protein metabolism.

Authors:  Rajeshwar Narlawar; Karlheinz Baumann; Robert Schubenel; Boris Schmidt
Journal:  Neurodegener Dis       Date:  2007       Impact factor: 2.977

6.  The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.

Authors:  Agnieszka Nikiforuk; Małgorzata Hołuj; Tomasz Kos; Piotr Popik
Journal:  Neuropharmacology       Date:  2016-01-28       Impact factor: 5.250

Review 7.  Cognitive function, dementia and type 2 diabetes mellitus in the elderly.

Authors:  Mark W J Strachan; Rebecca M Reynolds; Riccardo E Marioni; Jacqueline F Price
Journal:  Nat Rev Endocrinol       Date:  2011-02       Impact factor: 43.330

8.  Nicotinate-curcumin ameliorates cognitive impairment in diabetic rats by rescuing autophagic flux in CA1 hippocampus.

Authors:  Hong-Feng Gu; Na Li; Ya-Ling Tang; Can-Qun Yan; Zhe Shi; Si-Ni Yi; Hao-Ling Zhou; Duan-Fang Liao; Xin-Ping OuYang
Journal:  CNS Neurosci Ther       Date:  2018-09-09       Impact factor: 5.243

9.  Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurones in rat models of type 2 diabetes mellitus.

Authors:  Xiao-Jun Cai; Lei Wang; Chun-Mei Hu
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

10.  Autophagy facilitates organelle clearance during differentiation of human erythroblasts: evidence for a role for ATG4 paralogs during autophagosome maturation.

Authors:  Virginie M S Betin; Belinda K Singleton; Stephen F Parsons; David J Anstee; Jon D Lane
Journal:  Autophagy       Date:  2013-03-18       Impact factor: 16.016

View more
  6 in total

1.  Nicotinate-curcumin ameliorates cognitive impairment in diabetic rats by rescuing autophagic flux in CA1 hippocampus.

Authors:  Hong-Feng Gu; Na Li; Ya-Ling Tang; Can-Qun Yan; Zhe Shi; Si-Ni Yi; Hao-Ling Zhou; Duan-Fang Liao; Xin-Ping OuYang
Journal:  CNS Neurosci Ther       Date:  2018-09-09       Impact factor: 5.243

2.  The mTOR/NF-κB Pathway Mediates Neuroinflammation and Synaptic Plasticity in Diabetic Encephalopathy.

Authors:  Ting Xu; Jiao Liu; Xin-Rui Li; Yinghua Yu; Xuan Luo; Xian Zheng; Yuan Cheng; Pei-Quan Yu; Yi Liu
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

3.  Treatment with an Angiopoietin-1 mimetic peptide promotes neurological recovery after stroke in diabetic rats.

Authors:  Poornima Venkat; Ruizhuo Ning; Alex Zacharek; Lauren Culmone; Linlin Liang; Julie Landschoot-Ward; Michael Chopp
Journal:  CNS Neurosci Ther       Date:  2020-12-21       Impact factor: 7.035

4.  Nicotinate-curcumin inhibits AngII-induced vascular smooth muscle cell phenotype switching by upregulating Daxx expression.

Authors:  Si-Yu Sun; Yu-Mei Cao; Yan-Jie Huo; Fei Qiu; Wen-Juan Quan; Chao-Ping He; Yu Chen; Duan-Fang Liao; Qin-Hui Tuo
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

Review 5.  Autophagy and Diabetic Encephalopathy: Mechanistic Insights and Potential Therapeutic Implications.

Authors:  Li-Zhen Cheng; Wei Li; Yi-Xin Chen; Yi-Jia Lin; Ya Miao
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

6.  Curcumin nicotinate suppresses abdominal aortic aneurysm pyroptosis via lncRNA PVT1/miR-26a/KLF4 axis through regulating the PI3K/AKT signaling pathway.

Authors:  Jian-Ming Xiong; Hui Liu; Jie Chen; Qing-Qing Zou; Yang-Yi-Jing Wang; Guo-Shan Bi
Journal:  Toxicol Res (Camb)       Date:  2021-06-01       Impact factor: 2.680

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.